Azathioprine and Lymphadenopathy mediastinal - a phase IV clinical study of FDA data

Summary:

Lymphadenopathy mediastinal is reported as a side effect among people who take Azathioprine (azathioprine sodium), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Remicade, and have Colitis.

The phase IV clinical study analyzes which people have Lymphadenopathy mediastinal when taking Azathioprine. It is created by eHealthMe based on reports of 59,932 people who have side effects when taking Azathioprine from the FDA, and is updated regularly.

What is Azathioprine?

Azathioprine has active ingredients of azathioprine sodium. It is often used in crohn's disease. eHealthMe is studying from 60,623 Azathioprine users. Check the latest studies of Azathioprine.

What is Lymphadenopathy mediastinal?

Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs) is found to be associated with 518 drugs and 480 conditions by eHealthMe. Check the latest studies of Lymphadenopathy mediastinal.

On Jul, 26, 2026

59,932 people reported to have side effects when taking Azathioprine.
Among them, 18 people (0.03%) have Lymphadenopathy mediastinal.

Could Azathioprine cause Lymphadenopathy mediastinal?

Among these 18 people:

How long have people been on Azathioprine when they have Lymphadenopathy mediastinal? *

What is the gender of people who have Lymphadenopathy mediastinal when taking Azathioprine? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Lymphadenopathy mediastinal when taking Azathioprine? *

What are other drugs people take besides Azathioprine? *

What are other side effects people have besides Lymphadenopathy mediastinal? *

Fever: 7 people, 38.89%
Pleural Effusion (water on the lungs): 6 people, 33.33%
Fatigue (feeling of tiredness): 5 people, 27.78%
Cough: 5 people, 27.78%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 4 people, 22.22%
Respiratory Distress (difficulty in breathing): 4 people, 22.22%
Pneumonia: 3 people, 16.67%
Lung Neoplasm (tumour of lung): 3 people, 16.67%
Joint Pain: 3 people, 16.67%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 16.67%

What are the existing conditions these people have? *

Pain: 2 people, 11.11%
Immunodeficiency Disorders: 2 people, 11.11%
Colitis (inflammation of colon): 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Respiratory Disorder (respiratory disease): 1 person, 5.56%
Pulmonary Sarcoidosis (growth of tiny collections of inflammatory cells in lungs): 1 person, 5.56%
Nervousness: 1 person, 5.56%
Hypersensitivity: 1 person, 5.56%
Breast Cancer Stage Ii: 1 person, 5.56%
Autoimmune Neuropathy (disease or dysfunction of one or more peripheral nerves by autoimmune disorders): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Azathioprine and have Lymphadenopathy mediastinal?

- Check whether Lymphadenopathy mediastinal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azathioprine:

Azathioprine (60,623 reports)

Browse all side effects of Azathioprine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphadenopathy mediastinal:

Lymphadenopathy mediastinal (518 drugs)

Browse all the conditions that are associated with Lymphadenopathy mediastinal:

Lymphadenopathy mediastinal (480 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azathioprine sodium (the active ingredients of Azathioprine) and Azathioprine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.